Biotech experts, top LSD researchers, science specialists, influencers, and medical professionals are invited to attend the virtual LSD Conference being held on February 17, 2022. The agenda of the conference will include discussions, keynotes, and insights from world-class speakers focused on the research regarding therapeutic benefits and potential of LSD.
The conference is organized by Microdose, a premier organization engaged in creating, offering and distributing the most compelling content on the finance, industry news, science, and the latest breakthroughs and events of the psychedelic industry. This is the biggest platform offering exposure to professionals, companies, and individuals about the events of the psychedelic industry.
The title sponsor of the virtual event is MindBio Therapeutics, a clinical-stage drug development company engaged in the research of microdosing and the medicinal benefits of psychedelic medicines in treating debilitating mental illnesses.
This 2-day virtual event will explore the scope and potential of LSD along with discussing the latest innovations in drug development, clinical safety and care, the laws and regulations, science and research, culture and creativity, as well as business trends.
This LSD event offers a phenomenal platform and a huge breadth of audience. The attendees can interact with industry influencers and organizations who will discuss the future potential of LSD in different sectors. They will learn the varied uses of LSD and its potential non-psychedelic uses, its role in healing debilitating mental conditions, drug development and safety, clinical applications, and its creative effects, to name a few. This conference is a great networking medium where businesses and professionals can connect to build relationships and explore the latest innovations in psychedelic science.
The major points of discussion at the conference include:
- Therapeutic Use of LSD in Psychiatry
- Posology and Tolerance to Regression
- Safety and Efficacy of Lysergic Acid Diethylamide Assisted Psychotherapy
- LSD Microdosing
- Effect of Lysergic Acid Diethylamide (“LSD”) on Learning
- The Effects of LSD on Creativity
Attendees buying tickets to the event can attend the sessions, live presentations, group discussions as well as avail networking opportunities in one-to-one meetings with dedicated companies. Also, they will have lifetime access to the live recordings and will be added to the My content section of the website of every ticketholder’s account within 5 business days following the event.
For more information visit https://ibn.fm/xE23e.
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.investorwire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]
InvestorWire is part of the InvestorBrandNetwork.